Glenmark Pharmaceuticals has informed that it attached a press release today titled ‘Glenmark Pharmaceuticals Inc., USA continues to expand its Over-The-Counter (OTC) Portfolio with the acquisition of approved ANDAs from Wockhardt Limited’.
The above information is a part of company’s filings submitted to BSE.